
|Poll|September 12, 2022
POLL: Did You Attend the 31st Annual EADV Congress?
Author(s)Dermatology Times Staff
Click here to answer this week's poll.
Advertisement
Did You Attend the 31st Annual EADV Congress?
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis
2
FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis
3
Genetic Study Links Higher BMI to Perceived Facial Aging, but Causality Remains Unproven
4
Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials
5






